Clinical Trial Update: Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating generic pimecrolimus 1% cream for mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus Cream 1% (pimecrolimus)

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED